Entity Common Stock, Shares Outstanding of RELMADA THERAPEUTICS, INC. from 02 May 2013 to 10 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
RELMADA THERAPEUTICS, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 02 May 2013 to 10 Nov 2025.
  • RELMADA THERAPEUTICS, INC. Entity Common Stock, Shares Outstanding for the quarter ending 10 Nov 2025 was 73,333,622, a 143% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

RELMADA THERAPEUTICS, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 73,333,622 +43,159,420 +143% 10 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 33,191,622 +3,017,420 +10% 04 Aug 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 33,191,622 +3,017,420 +10% 25 Mar 2025 10-K 27 Mar 2025 2024 FY
Q3 2024 30,174,202 +74,999 +0.25% 04 Nov 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 30,174,202 +74,999 +0.25% 02 Aug 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 30,174,202 +74,999 +0.25% 15 Mar 2024 10-K 19 Mar 2024 2023 FY
Q3 2023 30,099,203 0 0% 06 Nov 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 30,099,203 +38,685 +0.13% 03 Aug 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 30,099,203 +729,713 +2.5% 20 Mar 2023 10-K 23 Mar 2023 2022 FY
Q3 2022 30,099,203 +12,568,373 +72% 07 Nov 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 30,060,518 +12,587,532 +72% 09 Aug 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 29,369,490 +12,623,560 +75% 21 Mar 2022 10-K 25 Mar 2022 2021 FY
Q3 2021 17,530,830 +1,289,304 +7.9% 10 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 17,472,986 +1,449,040 +9% 06 Aug 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 16,745,930 +1,806,122 +12% 15 Mar 2021 10-K 24 Mar 2021 2020 FY
Q3 2020 16,241,526 -23,337,460 -59% 09 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 16,023,946 05 Aug 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 14,939,808 -18,317,179 -55% 26 Mar 2020 10-KT 26 Mar 2020 2019 FY
Q3 2019 39,578,986 +27,029,116 +215% 24 Sep 2019 10-K 24 Sep 2019 2019 FY
Q1 2019 33,256,987 +20,708,117 +165% 14 May 2019 10-Q 15 May 2019 2019 Q3
Q4 2018 30,266,373 +17,718,753 +141% 13 Feb 2019 10-Q 13 Feb 2019 2019 Q2
Q3 2018 12,549,870 +4,750 +0.04% 28 Sep 2018 10-K 28 Sep 2018 2018 FY
Q1 2018 12,548,870 +508,958 +4.2% 14 May 2018 10-Q 14 May 2018 2018 Q3
Q4 2017 12,547,620 +511,708 +4.3% 12 Feb 2018 10-Q 12 Feb 2018 2018 Q2
Q3 2017 12,545,120 +510,083 +4.2% 28 Sep 2017 10-K 28 Sep 2017 2017 FY
Q1 2017 12,039,912 +20,750 +0.17% 15 May 2017 10-Q 15 May 2017 2017 Q3
Q4 2016 12,035,912 +36,790 +0.31% 20 Jan 2017 10-Q 10 Feb 2017 2017 Q2
Q3 2016 12,035,037 +1,220,124 +11% 09 Sep 2016 10-K 09 Sep 2016 2016 FY
Q1 2016 12,019,162 -41,723,862 -78% 09 May 2016 10-Q 09 May 2016 2016 Q3
Q4 2015 11,999,122 -41,681,923 -78% 05 Feb 2016 10-Q 05 Feb 2016 2016 Q2
Q3 2015 10,814,913 -29,486,804 -73% 11 Sep 2015 10-K 11 Sep 2015 2015 FY
Q1 2015 53,743,024 +25,243,024 +89% 15 May 2015 10-Q 15 May 2015 2015 Q3
Q4 2014 53,681,045 +25,181,045 +88% 13 Feb 2015 10-Q 13 Feb 2015 2015 Q2
Q3 2014 40,301,717 02 Sep 2014 10-KT 09 Sep 2014 2014 FY
Q1 2014 28,500,000 +5,000,000 +21% 14 Apr 2014 10-Q 15 Apr 2014 2014 Q2
Q4 2013 28,500,000 14 Jan 2014 10-Q 13 Jan 2014 2014 Q1
Q2 2013 23,500,000 10 Jul 2013 10-Q 12 Jul 2013 2013 Q3
Q1 2013 23,500,000 02 May 2013 10-Q 03 May 2013 2013 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.